Pramipexole

규격

104632-26-0CAS 번호

600-593-1EC 번호

(6S)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamineIUPAC 명칭

C10H17N3S화학식

211.33 g/mol분자량

pramipexole; 104632-26-0; (-)-Pramipexole; Pramipexol; Mirapexin; Pramipexolum; Sifrol; SUD919CL2Y; Mirapex; U-98528E; Pramipexolum [Latin]; DTXSID6023496; (6S)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine; (6S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine; SUD-919CL2Y; CTC-501; 83619PEU5T; NSC-760426; 2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-; CHEBI:8356; DTXCID203496; Pramipexolum (Latin); 2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N6-propyl-, (S)-; (6S)-N'-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine; Neliprax; Pipexus; 2-amino-4,5,6,7-tetrahydro-6-propylaminobenzothiazole; RefChem:56732; N04BC05; 2 Amino 6 propylaminotetrahydrobenzothiazole; 4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine; (S)-N 6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine; (S)-Pramipexole; (S)-N6-Propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine; Oprymea; MFCD00869076; (S)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole; SND-919; PRAMIPEXOLE HCl; CHEMBL301265; (6S)-4,5,6,7-Tetrahydro-N6-propyl-2,6-benzothiazolediamine; (S)-N6-Propyl-4,5,6,7-tetrahydrobenzothiazole-2,6-diamine; 2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N6-propyl-, (6S)-; PRAMIPEXOLE HYDROCHLORIDE; NCGC00167441-01; SND 919; (6S)-N(6)-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine; Pramipexol [Spanish]; SMR000449298; CAS-104632-26-0; SR-01000763219; Pramipexole (USAN/INN); SUD 919CL2Y; UNII-83619PEU5T; Pramipexole [USAN:INN:BAN]; (-) Pramipexole; 556801-24-2; Pramipexole (Standard); Spectrum_001838; 111GE001; SpecPlus_000820; PRAMIPEXOLE [MI]; Spectrum5_001453; PRAMIPEXOLE [INN]; PRAMIPEXOLE [USAN]; EC 600-593-1; PRAMIPEXOLE [VANDF]; SCHEMBL35376; GTPL953; KBioSS_002343; PRAMIPEXOLE [WHO-DD]; MLS000758250; MLS001423952; BIDD:GT0250; DivK1c_006916; orb1227067; orb1308531; HSDB 8253; HY-B0410R; KBio1_001860; KBio2_002340; KBio2_004908; KBio2_007476; (s)-2-amino-6-propylamino-4,5,6,7-tetrahydrobenzothiazole; GLXC-07798; HMS2051A21; HMS2090C15; HMS2232B03; HMS3884L19; (S)-2-amino-6-propylamino-4,5,6,7-tetrahydrobenzthiazole;(S)-2-amino-6-propylamino-4,5,6,7-tetrahydrobenzthiazole; HY-B0410; MSK11202; Tox21_112445; BDBM50116766; CX1349; EBC-26212; AKOS016843188; Tox21_112445_1; CCG-100823; DB00413; FP45322; NC00073; NSC 760426; NCGC00167441-02; NCGC00167441-03; NCGC00167441-08; NCGC00167441-10; DS-14807; SY009549; DB-038042; NS00098767; P2879; SW197453-4; D05575; EN300-150086; AB00053772-12; AB00053772-13; AB00053772_14; AB00053772_16; F225637; Q421304; SR-01000763219-5; SR-01000763219-6; BRD-K06388322-001-07-4; BRD-K06388322-312-02-6; (6S)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine; (s)-(-)-2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole; (6S)-N~6~-Propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine; (S)-N 6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine동의어